(June 16, 2022, 6:50 AM EDT) -- SAN FRANCISCO — In a June 3 order, a federal judge in California granted preliminary approval of a settlement between Bristol-Myers Squibb Co. (BMS) and a class of direct purchasers of various combination antiretroviral therapy (cART) drugs used for the treatment of human immunodeficiency virus (HIV)....